Kilitch Drugs(I) Share Price
Small Cap | Pharmaceuticals and health care | NSE: KILITCH | BSE: 524500
₹315.00 
4.45 (1.43 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 316.00
High (₹) 317.40
Low (₹) 312.00
Prev. Close (₹) 310.55
Volume 77
VWAP (₹) 306.36
ROCE (%) 14.37
Industry P/E 43.95
TTM P/E 25.97
P/B Ratio 2.88
Market Cap (₹) Cr.505.95
Dividend Yield (%)--
EPS (₹) 9.17
ROE8.40%
Sales Growth (%) 10.58
Profit Growth (%)63.90
Day Range
317.40317.40
52 Week Range
293.95404.90
Historical Returns
Returns (6M)
-18.72 %
Returns (1Y)
-12.83 %
Returns (3Y)
77.92 %
Returns (5Y)
248.64 %
Returns (6M)
-18.72 %
Returns (1Y)
-12.83 %
Returns (3Y)
77.92 %
Returns (5Y)
248.64 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (36.66%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 36.66% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 50.13
MFI 39.18
ATR 18.72
Commodity Channel Index -122.98
ROC125 -9.72
ROC21 -1.54
Williams %R -79.86
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 312.16 | 317.48 | 322.91 | 306.73 | 301.41 | 295.98 | 290.66 |
| Week Ago | 327.94 | 330.67 | 332.14 | 326.47 | 323.74 | 322.27 | 319.54 |
| Month Ago | 314.14 | 316.57 | 318.14 | 312.57 | 310.14 | 308.57 | 306.14 |
EMA & SMA
315.00
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 321.74
9 Day 317.96
10 Day 316.30
12 Day 317.85
14 Day 318.92
20 Day 318.01
26 Day 319.90
50 Day 324.32
100 Day 322.46
200 Day 333.72
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 28 Aug, 2024 | Bhavin Mukund Mehta | Disposal | ₹ | 8,41,046 | BSE |
| 28 Aug, 2024 | Mira Bhavin Mehta | Acquisition | ₹ | 8,41,046 | BSE |
| 25 Apr, 2022 | Bhavin Mukund Mehta | Acquisition | ₹ | 11,11,768 | BSE |
| 25 Apr, 2022 | Mukund Mehta | Disposal | ₹ | 11,11,768 | BSE |
| 12 Apr, 2022 | Mukund Mehta | Acquisition | ₹ | 11,11,768 | BSE |
| 29 Oct, 2020 | Mr. Bhavin Mehta | Revoke | ₹99.00 | 1,03,300 | BSE |
| 29 Oct, 2020 | Mr. Bhavin Mehta | Pledge | ₹92.50 | 1,03,300 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 14 Feb, 2025 | NSE India | Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication |
| 12 Feb, 2025 | BSE India | Enclosed herewith the press release relating to 3FY25 financial results of the Company |
| 12 Feb, 2025 | NSE India | Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated February 12, 2025, titled ""Financial Results Q3FY25"". |
| 11 Feb, 2025 | NSE India | We are submitting herewith the integrated filing (financials) for the quarter ended 31st December, 2024 |
| 11 Feb, 2025 | BSE India | We are submitting herewith the integrated filing (financials) for the quarter ended 31st December, 2024 |
| 11 Feb, 2025 | NSE India | Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 11 Feb, 2025 | BSE India | Considered and Approved unaudited financial results for quarter ending 31st December, 2024 |
| 04 Feb, 2025 | BSE India | Mr. Bhavin Mukund Mehta, Wholetime Director appointed as Vice Chairman of PHARMEXCIL |
| 04 Feb, 2025 | NSE India | Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated February 04, 2025, titled ""Bhavin Mehta, Director appointed as vice chairman of PHARMEXCIL"". |
| 03 Feb, 2025 | NSE India | KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 04 Feb, 2025 | 11 Feb, 2025 |
| Quarterly Results | -- | 05 Nov, 2024 | 12 Nov, 2024 |
| Quarterly Results | -- | 02 Aug, 2024 | 08 Aug, 2024 |
| Quarterly Results | -- | 22 May, 2024 | 27 May, 2024 |
| Quarterly Results | -- | 01 Feb, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 02 Nov, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 11 Aug, 2023 |
| Others | To consider and approve conversion of warrants into the equity shares of the Company to the specified person only. | 24 Jul, 2023 | 22 Jul, 2023 |
| Audited Results | -- | 18 May, 2023 | 29 May, 2023 |
| Quarterly Results | -- | 06 Feb, 2023 | 14 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Kilitch Drugs(I)
Kilitch Drugs(I) is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 131.60 Cr. and Equity Capital is Rs. 16.08 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1992
Managing Director
Mr. Mukund P Mehta
NSE Symbol
KILITCH
Kilitch Drugs(I) Management
| Name | Designation |
|---|---|
| Mr. Mukund P Mehta | Managing Director |
| Mr. Bhavin Mukund Mehta | Whole Time Director |
| Mrs. Mira B Mehta | Whole Time Director |
| Mr. Hemang J Engineer | Independent Director |
| Mr. Venkita Subramanian Rajan | Independent Director |
| Prof. Vasudev Krishna Murti | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Kilitch Drugs(I)
What is the share price of Kilitch Drugs(I)?
The share price of Kilitch Drugs(I) on 13 Mar, 2025 is ₹ 315.00.
What is 52W high and 52W low share price of Kilitch Drugs(I)?
The highest and lowest 52W share prices of Kilitch Drugs(I) are ₹ 404.900 and ₹ 293.950
What is the market cap of Kilitch Drugs(I)?
The market capitalization of Kilitch Drugs(I) as of 13 Mar, 2025 is ₹ 505.95 Crores
What is the P/E ratio of Kilitch Drugs(I)?
The current P/E ratio of Kilitch Drugs(I) as of 13 Mar, 2025 is 43.95
What is the PB ratio of Kilitch Drugs(I)?
The PB ratio of Kilitch Drugs(I) as of 13 Mar, 2025 is 2.88
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)